Trial Profile
An Open-Label, Two Period Study to Determine the Excretion Balance and Pharmacokinetics of [14C]-GSK221149A, Administered as Single Doses of an Oral Solution and an Intravenous Infusion to Healthy Female Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Aug 2023
Price :
$35
*